Literature DB >> 22156778

Hot off the breath: triple therapy for idiopathic pulmonary fibrosis--hear the PANTHER roar.

Emmet E McGrath, Ann B Millar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22156778     DOI: 10.1136/thoraxjnl-2011-201398

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  5 in total

1.  Ibrutinib Exacerbates Bleomycin-Induced Pulmonary Fibrosis via Promoting Inflammation.

Authors:  Yangyang Gu; Bo Huang; Yanfei Yang; Mengdie Qi; Guohua Lu; Dajing Xia; Hequan Li
Journal:  Inflammation       Date:  2018-06       Impact factor: 4.092

2.  Superoxide Dismutase 3 R213G Single-Nucleotide Polymorphism Blocks Murine Bleomycin-Induced Fibrosis and Promotes Resolution of Inflammation.

Authors:  Gary C Mouradian; Rohit Gaurav; Steve Pugliese; Karim El Kasmi; Brittany Hartman; Laura Hernandez-Lagunas; Kurt R Stenmark; Russell P Bowler; Eva Nozik-Grayck
Journal:  Am J Respir Cell Mol Biol       Date:  2017-03       Impact factor: 6.914

3.  Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis.

Authors:  Daryle J DePianto; Sanjay Chandriani; Alexander R Abbas; Guiquan Jia; Elsa N N'Diaye; Patrick Caplazi; Steven E Kauder; Sabyasachi Biswas; Satyajit K Karnik; Connie Ha; Zora Modrusan; Michael A Matthay; Jasleen Kukreja; Harold R Collard; Jackson G Egen; Paul J Wolters; Joseph R Arron
Journal:  Thorax       Date:  2014-09-12       Impact factor: 9.139

Review 4.  Efficacy of N-Acetylcysteine in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis.

Authors:  Tong Sun; Jing Liu; De Wei Zhao
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

5.  The efficacy and safety of pinocembrin in a sheep model of bleomycin-induced pulmonary fibrosis.

Authors:  Habtamu B Derseh; Jason Q D Goodger; Jean-Pierre Y Scheerlinck; Chrishan S Samuel; Ian E Woodrow; Enzo A Palombo; Alistair Cumming; Ken Snibson
Journal:  PLoS One       Date:  2021-12-02       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.